Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index; 20 of the 79 sources its claims cite were checked for support.
Abstract
The treatment of depressive symptoms of bipolar disorder (BD) has received increasing attention. Recently, some studies have shown that bright light therapy (BLT) seems to be useful for BD depression. This meta-analysis is intended to further elucidate the role of BLT in depressive symptoms in patients with BD. Register of Systematic Reviews PROSPERO: CRD 420191 33642.Randomized controlled trials and cohort studies were retrieved in PubMed, Cochrane Library, EMbase, Web of Science, CINHAL, CBM, CNKI, VIP, and Wanfang from their foundation to March 2020, and other sources as supplement was also retrieved. Data were extracted after strict evaluation of literature quality by two researchers, and Meta-analysis was conducted on literatures that met the inclusion criteria. Meta-analysis was performed using Revman 5.3 software. In total, 12 studies including 847 patients with BD depression were included in our meta-analysis. A meta-analysis found significant differences between BLT and placebo for the following outcomes: (1) depression severity before and after BLT [SMD = -0.43, 95% CI (-0.73,-0.13), P<0.05] in RCT and [SMD = -2.12, 95% CI (-2.3,-1.94), P<0.05] in cohort studies.; (2) the efficacy of duration/timing of light therapy for depressive symptoms in BD [I2 = 85%, SMD = -1.88, 95% CI (-2.04, -1.71),P<0.05] and [I2 = 71%, SMD = -2.1,95% CI(-2.24, -1.96), P<0.05]; (3) the efficacy of different color/color temperatures for depressive symptoms in BD [I2 = 0%, SMD = -0.56, 95% CI (-0.92, -0.19), P<0.05] and [I2 = 97%, SMD = -1.74, 95% CI (-1.99, -1.49), P<0.05].We performed a subgroup meta-analysis of studies that used different light intensities. The results showed that light intensity≥5000 lux significantly reduced the severity of depression. And patients without psychotropic drugs revealed significantly decreased disease severity [I2 = 0%, SMD = -0.6, 95% CI (-1.06,-0.13), P<0.05]. Limitations of the study include studies only assessed short-term effects, and insufficient duration may underestimate adverse reactions and efficacy. Our results highlight the significant efficiency of BLT in the treatment of bipolar depression. Prospective studies with more rigorous design and consistent follow-up.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that bright light therapy (BLT) significantly reduced depressive symptom severity in patients with bipolar disorder (BD), with effects observed across RCTs and cohort studies. Subgroup analyses suggested efficacy across different durations/timings, colors/color temperatures, light intensities, and with or without psychotropic drugs, though the authors caution that evidence remains limited.
Key findings
- BLT significantly reduced depression severity: RCTs [SMD = -0.43, 95% CI (-0.73, -0.13), P<0.05]; cohort studies [SMD = -2.12, 95% CI (-2.3, -1.94), P<0.05].
- Duration/timing analyses showed significant effects for phototherapy <10 h [I² = 85%, SMD = -1.88, 95% CI (-2.04, -1.71), P<0.05] and for morning plus night light therapy [I² = 71%, SMD = -2.1, 95% CI (-2.24, -1.96), P<0.05].
- White light therapy significantly decreased disease severity in RCTs [I² = 0%, SMD = -0.56, 95% CI (-0.92, -0.19), P<0.05]; color temperatures >4500 K [I² = 93%, SMD = -2.06, 95% CI (-2.23, -1.88), P<0.05] and <4500 K [I² = 97%, SMD = -1.74, 95% CI (-1.99, -1.49), P<0.05] also showed significant effects.
- Light intensity ≥5000 lux significantly reduced severity in RCTs [I² = 33%, SMD = -0.38, 95% CI (-0.73, -0.04), P<0.05] and cohort studies after sensitivity analysis [I² = 29%, SMD = -2.17, 95% CI (-2.37, -1.98), P<0.05]; patients without psychotropic drugs also showed decreased severity in RCTs [I² = 0%, SMD = -0.6, 95% CI (-1.06, -0.13), P<0.05].
Methods
- Systematic review and meta-analysis conducted per PRISMA and Cochrane Handbook, registered as PROSPERO CRD 420191 33642.
- Searched PubMed, Cochrane Library, Embase, Web of Science, CINHAL, CBM, CNKI, VIP, and Wanfang from inception to March 2020; included RCTs and cohort studies of BLT for depressive symptoms in BD, excluding incomplete data and pregnant women.
- Included 12 studies (5 RCTs, 7 cohort studies) with 847 patients with BD depression; quality assessed with Newcastle Ottawa Scale for cohort studies and Cochrane risk-of-bias tool for RCTs; meta-analysis performed in RevMan 5.3 using SMD with 95% CI, heterogeneity assessed by χ² and I², with separate RCT/cohort and subgroup analyses.
Limitations
- The paper states included studies only assessed short-term effects, and insufficient duration may underestimate adverse reactions and efficacy; rigorously designed RCTs are needed.
- The paper states existing evidence is not sufficient and there are no uniform standards for light box use or light intensity; prospective studies with more rigorous design and consistent follow-up are needed.
- Text-evident limitations include high heterogeneity in several analyses (e.g., I² = 85%, 97%, 93%, 75%), small numbers in some subgroups (e.g., only 2 studies with light intensity ≤5000 lux; only 2 studies applied BLT as sole intervention), and one cohort study (Sikkens et al.) introducing heterogeneity and scoring only 5 points on the NOS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
7 Valid · 7 Not valid · 12 Not checked · 55 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Sensitivity analysis, revealed significantly decreased disease severity in BD patients after BLT without psychotropic drugs in RCTs [I2 = 0%, SMD = -0.6, 95% CI (-1.06,-0.13), P<0.05] (Fig 15)”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Subgroup meta-analysis results of studies without psychotropic drugs
What the sources say
- Not checked — no full text of the sourcecites [45] Tseng PT, Chen YW, Tu KY, Chung W, Wang HY, Wu CK, et al Light therapy in the treatment of patients with bipolar depression: A meta-analytic study. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. 2016; 26(6): 1037– 47. 10.1016/j.euroneuro.2016.03.001 26993616 source
- Not checked — no full text of the sourcecites [50] Gøtzsche PC, Hróbjartsson A, Maric K, Tendal B. Data extraction errors in meta-analyses that use standardized mean differences. Jama. 2007; 298(4): 430– 7. 10.1001/jama.298.4.430 17652297 source
- Partly supportedcites [54] Sikkens D, Lek RFR-vd, Meesters Y, Schoevers RA, Haarman BCM. Combined sleep deprivation and light therapy: clinical treatment outcomes in patients with complex unipolar and bipolar depression. Journal of Affective Disorders. 2018. 30611915 sourceExperimental — accuracy not yet measured
The Results report significantly lower depression scores after treatment in the BD group. But the Discussion says this was not an RCT, and the treatment combined sleep deprivation with light therapy; patients also used psychotropic medication. The paper does not report the cited sensitivity-analysis statistics (I², SMD, or confidence interval). (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“and cohort studies [I2 = 75%, SMD = -1.99, 95% CI (-2.43,-1.55), P<0.05] (Fig 15).”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Subgroup meta-analysis results of studies without psychotropic drugs
What the sources say
- Could not verifycites [46] Takeshima M, Utsumi T, Aoki Y, Wang Z, Suzuki M, Okajima I, et al Efficacy and safety of bright light therapy for manic and depressive symptoms in patients with bipolar disorder: A systematic review and meta-analysis. Psychiatry and clinical neurosciences. 2020 10.1111/pcn.12976 31917880 PMC7187384 sourceExperimental — accuracy not yet measured
The Methods (Inclusion criteria; page not provided) limit this review to randomized controlled trials, and the Results (Study characteristics; page not provided) say all included studies were RCTs with varying medication use. The copy does not report an analysis of cohort studies without psychotropic drugs or the claimed I², SMD, and confidence interval; its nonsignificant RCT comparison does not resolve that separate claim. (LLM, conf=0.77)
- Not checked — no full text of the sourcecites [47] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology. 2010; 25(9): 603– 5. 10.1007/s10654-010-9491-z 20652370 source
- Not checked — no full text of the sourcecites [48] Shuster JJ. Review: Cochrane handbook for systematic reviews for interventions, Version 5.1.0, published 3/2011. Julian P.T. Higgins and Sally Green, Editors. Research Synthesis Methods. 2011; 2(2): 126– 30. source
- Not checked — no full text of the sourcecites [55] Suzuki M, Dallaspezia S, Locatelli C, Uchiyama M, Colombo C, Benedetti F. Does early response predict subsequent remission in bipolar depression treated with repeated sleep deprivation combined with light therapy and lithium? Journal of Affective Disorders. 2018; 229: 371– 6. 10.1016/j.jad.2017.12.066 29331696 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
In the paper
“our subgroup analysis revealed that the study by Sikkens et al. (2018) introduced significant, heterogeneity that almost disappeared after its omission.”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Discussion
What the sources say
- Not matchedcites Sikkens et al. (2018)
An author–year citation the paper’s reference list doesn’t settle. We don’t search these by name.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In total, 12 studies including 847 patients with BD depression were included in our meta-analysis.”
- Also stated in: § Study and patient characteristics · plain
“A total of 12 articles including 5 RCTs and 7 cohort studies were include with samples of 7220 patients for a total of 847 cases.”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Abstract
plainn = 847- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Study and patient characteristics · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“And patients without psychotropic drugs revealed significantly decreased disease severity [I2 = 0%, SMD = -0.6, 95% CI (-1.06,-0.13), P<0.05].”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
39 more claims
Create a free account to see all 81 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 18
- Probably not a substantial claim. 20
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The antidepressant effect was achieved even when low (<5000 lux) light intensity was used (Dallaspezia and Benedetti 2020; Wang et al. 2020)”
From Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force (2025) · cites this paper as Wang et al. 2020
The cited source says what the claim attributes to it.
In the citing paper
“Patients with BD may be sensitive to lower light intensities (< 10 000 lux) so the protocols may vary (Dallaspezia and Benedetti 2020; Wang et al. 2020).”
From Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force (2025) · cites this paper as Wang et al. 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“[I2 = 0%, SMD = -2.16, 95% CI (-2.31,-2.12, P<0.05]”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Subgroup meta-analysis results of studies with or without auxiliary measures
Reported -2.16 · recomputed -2.215
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Subgroup meta-analysis result of studies with different light intensities
“There were 3 studies with light intensities≤5000 lux,2 cohort studies [52,53], and 1 RCT [54].”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Study and patient characteristics
“| Zhou2018 | China | 37/37 | DSM-IV | BD, depress | 35.1±14.2 | 14 | 4000 | morning | 5000 | White | Yes | RCT | B |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Subgroup meta-analysis results of studies with or without auxiliary measures
“Analysis of the RCTs revealed significantly decreased depression severity in BD patients after BLT with auxiliary measures”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Subgroup meta-analysis results of studies with or without auxiliary measures
“Five articles did not use auxiliary measures, 4 RCTs and 1 cohort study.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Main meta-analysis results
“There was less heterogeneity between RCTs [44,45,50,51,54] (I2 = 20%, P = 0.29), so a random effects model was employed.”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Materials and methods > Statistical analysis
“If there was no statistical heterogeneity between study results, a fixed effect model was used for meta-analysis; if there a random effect model was employed.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Main meta-analysis results
“A total of 12 articles [44–55] were included.”
§ Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis > Results > Literature search results
“According to the inclusion and exclusion criteria, 12 were selected after screening [52–63].”
Citations
Cites
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Analysing data and undertaking meta‐analyses
Deeks, J. J., Higgins, J. P., Altman, D. G., & on behalf of the Cochrane Statistical Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch10 · Cited by 2,672
Light Suppresses Melatonin Secretion in Humans
Lewy, A. J., Wehr, T. A., Goodwin, F. K., Newsome, D. A., & Markey, S. P. (1980) · Science · doi:10.1126/science.7434030 · Cited by 1,913
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Prevalence and incidence studies of anxiety disorders: A systematic review of the literature
Somers, J. M., Goldner, E. M., Waraich, P., & Hsu, L. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100206 · Cited by 1,114
Geddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848 · cited 1×
“Besides pharmacologic treatment, studies have assessed the use of cognitive-behavioral therapy, social rhythm therapy, and family-centered treatment [32,64,71,72].”
BackgroundTwo-Year Outcomes for Interpersonal and Social Rhythm Therapy in Individuals With Bipolar I Disorder
Frank, E., Kupfer, D. J., Thase, M. E., Mallinger, A. G., Swartz, H. A., Fagiolini, A. M., Grochocinski, V., Houck, P., Scott, J., Thompson, W., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.996 · Cited by 770
A systematic review of the mortality of depression
Wulsin, L. R., Vaillant, G. E., & Wells, V. E. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199901000-00003 · Cited by 703
Bipolar disorder diagnosis: challenges and future directions
Phillips, M. L., & Kupfer, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60989-7 · Cited by 665
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 578
Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature
Waraich, P., Goldner, E. M., Somers, J. M., & Hsu, L. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900208 · Cited by 522
Expressed Emotion and Relapse of Psychopathology
Hooley, J. M. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095236 · Cited by 499
Kessler, R. C., Abelson, J., Demler, O., Escobar, J. I., Gibbon, M., Guyer, M. E., Howes, M. J., Jin, R., Vega, W. A., Walters, E. E., et al. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.169 · Cited by 489
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
Takeshima, N., Sozu, T., Tajika, A., Ogawa, Y., Hayasaka, Y., & Furukawa, T. A. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-30 · Cited by 387 · cited 1×
“The MD is the difference in the means of the treatment group and the control group, while the SMD is the MD divided by the standard deviation (SD) [49].”
MethodColom, F., Vieta, E., Sánchez-Moreno, J., Palomino-Otiniano, R., Reinares, M., Goikolea, J. M., Benabarre, A., & Martínez-Arán, A. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.040485 · Cited by 384
Miura, T., Noma, H., Furukawa, T. A., Mitsuyasu, H., Tanaka, S., Stockton, S., Salanti, G., Motomura, K., Shimano-Katsuki, S., Leucht, S., et al. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70314-1 · Cited by 364 · cited 1×
“Mood stabilizers and antipsychotics are the mainstays of acute treatment for mania and depression in BD [19], and lithium is considered to be one of the most effective treatments for preventing both types of symptoms [20].”
BackgroundLeverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., Keck, P. E., McElroy, S. L., Denicoff, K. D., Obrocea, G., Nolen, W. A., Kupka, R., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0503 · Cited by 352
Relapse Prevention in Patients With Bipolar Disorder: Cognitive Therapy Outcome After 2 Years
Lam, D. H., Hayward, P., Watkins, E. R., Wright, K., & Sham, P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.324 · Cited by 347 · cited 1×
“Besides pharmacologic treatment, studies have assessed the use of cognitive-behavioral therapy, social rhythm therapy, and family-centered treatment [32,64,71,72].”
BackgroundKreutzmann, J. C., Havekes, R., Abel, T., & Meerlo, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.053 · Cited by 309
Shuster, J. J. (2011) · Research Synthesis Methods · doi:10.1002/jrsm.38 · Cited by 297
Wu, J. C., Kelsoe, J. R., Schachat, C., Bunney, B. G., DeModena, A., Golshan, S., Gillin, J. C., Potkin, S. G., & Bunney, W. E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.018 · Cited by 263 · cited 1×
“05],while the other two cohort studies [58,59] showed green light therapy resulted in significantly decreased disease severity in BD patients[I(2) = 0%, SMD = -1.”
ResultLight therapy for non-seasonal depression
Tuunainen, A., Kripke, D. F., & Endo, T. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004050.pub2 · Cited by 261 · cited 1×
“BLT is recognized as an alternative to psychotherapy and psychopharmacology for treating adults with depression [73], and there is ample evidence that morning BLT is effective and safe for depression in BD [74–77].”
BackgroundData Extraction Errors in Meta-analyses That Use Standardized Mean Differences
Gøtzsche, P. C., Hróbjartsson, A., Marić, K., & Tendal, B. (2007) · JAMA · doi:10.1001/jama.298.4.430 · Cited by 238 · cited 6×
“7 articles were include: 2RCTs [50,51] and 5 cohort studies [53–56,61], that were discussed separately according to the study design.”
BackgroundMethodResultInfluentialBipolar II disorder: arguments for and against a distinct diagnostic entity
Vieta, E., & Suppes, T. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00561.x · Cited by 200
Epidemiology of Bipolar Disorders
Bauer, M., & Pfennig, A. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463003.x · Cited by 199
Gottlieb, J. F., Benedetti, F., Geoffroy, P. A., Henriksen, T. E. G., Lam, R. W., Murray, G., Phelps, J., Sit, D., Swartz, H. A., Crowe, M., et al. (2019) · Bipolar Disorders · doi:10.1111/bdi.12847 · Cited by 196 · cited 2×
“and Chronotherapy [43] recommended BLT had the strongest evidence among current chronotherapeutic options.”
BackgroundInfluentialMachado-Vieira, R., Salvadore, G., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0610 · Cited by 195
Sit, D. K., McGowan, J., Wiltrout, C., Diler, R. S., Dills, J. (., Luther, J., Yang, A., Ciolino, J. D., Seltman, H., Wisniewski, S. R., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16101200 · Cited by 186 · cited 1×
“There were 3 studies with light intensities�5000 lux,2 cohort studies [52,53], and 1 RCT [54].”
BackgroundBenedetti, F., Barbini, B., Fulgosi, M. C., Colombo, C., Dallaspezia, S., Pontiggia, A., & Smeraldi, E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1207 · Cited by 180
Chronotherapeutics for Affective Disorders: A Clinician's Manual for Light and Wake Therapy
Wirz‐Justice, A., Benedetti, F., & Terman, M. (2009) · Cited by 168
Morning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial
Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., & Smeraldi, E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0605 · Cited by 152
Grunze, H. (2011) · FOCUS: The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.9.4.500 · Cited by 149
Mixed states in DSM-5: Implications for clinical care, education, and research
Vieta, E., & Valentí, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.007 · Cited by 146
Vieta, E., & Phillips, M. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm057 · Cited by 146
Stephenson, K. M., Schroder, C. M., Bertschy, G., & Bourgin, P. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.09.002 · Cited by 140
Benedetti, F., Riccaboni, R., Locatelli, C., Poletti, S., Dallaspezia, S., & Colombo, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08455 · Cited by 116 · cited 2×
“4 articles [50,52,56,57] used morning light therapy [I(2) = 42%, SMD = -0.”
MethodBehavioral Treatment of Insomnia in Bipolar Disorder
Kaplan, K. A., & Harvey, A. G. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12050708 · Cited by 115
Assessment and management of bipolar disorder: summary of updated NICE guidance
Kendall, T., Morriss, R., Mayo-Wilson, E., Marcus, E., & on behalf of the Guideline Development Group (2014) · BMJ · doi:10.1136/bmj.g5673 · Cited by 112
Bright light as a personalized precision treatment of mood disorders
Maruani, J., & Geoffroy, P. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00085 · Cited by 112
Perspectives in affective disorders: Clocks and sleep
Wirz‐Justice, A., & Benedetti, F. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14362 · Cited by 108
Light therapy in the treatment of patients with bipolar depression: A meta-analytic study
Tseng, P.-T., Chen, Y.-W., Tu, K.-Y., Chung, W., Wang, H.-Y., Wu, C.-K., & Lin, P.-Y. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.001 · Cited by 100 · cited 5×
“There was less heterogeneity between RCTs [44,45,50,51,54] (I(2) = 20%, P = 0.”
BackgroundResultInfluentialGeoffroy, P. A., Schroder, C. M., Reynaud, E., & Bourgin, P. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101213 · Cited by 100 · cited 3×
“In this metaanalysis, only 2 studies [44,45] applied BLT as the sole intervention, underscoring the need for more large-sample RCTs.”
BackgroundResultBenedetti, F., Dallaspezia, S., Fulgosi, M. C., Barbini, B., Colombo, C., & Smeraldi, E. (2007) · Chronobiology International · doi:10.1080/07420520701649455 · Cited by 97 · cited 1×
“There were 4 studies with phototherapy greater than 10 hours, including 3 RCTs [50,51,56] and 1 cohort study [61] [I(2) = 45%, SMD = -0.”
BackgroundPrice, A. L., & Marzani-Nissen, G. (2012) · PubMed · Cited by 97
Antidepressants and the Risk of Suicidal Behaviors
MAANY, I. (2004) · JAMA · doi:10.1001/jama.292.23.2833-b · Cited by 82
Desan, P. H., Weinstein, A. J., Michalak, E. E., Tam, E. M., Meesters, Y., Ruiter, M. J., Horn, E., Telner, J., Iskandar, H., Boivin, D. B., et al. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-38 · Cited by 74
Lam, R. W., Teng, M. Y., Jung, Y.-E., Evans, V. C., Gottlieb, J. F., Chakrabarty, T., Michalak, E. E., Murphy, J. K., Yatham, L. N., & Sit, D. K. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719892471 · Cited by 70
Dauphinais, D. R., Rosenthal, J. Z., Terman, M., DiFebo, H. M., Tuggle, C., & Rosenthal, N. E. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.01.015 · Cited by 63
Genetic Factors Affecting Seasonality, Mood, and the Circadian Clock
Garbazza, C., & Benedetti, F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00481 · Cited by 61
An update on antidepressant use in bipolar depression
Sidor, M. M., & MacQueen, G. M. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0323-6 · Cited by 57
Benedetti, F., Calabrese, G., Bernasconi, A., Cadioli, M., Colombo, C., Dallaspezia, S., Falini, A., Radaelli, D., Scotti, G., & Smeraldi, E. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.08.004 · Cited by 53 · cited 2×
“We found that in one RCT study [60], P was greater than 0.”
BackgroundZhou, T.-H., Dang, W.-M., Ma, Y.-T., Hu, C.-Q., Wang, N., Zhang, G.-Y., Wang, G., Shi, C., Zhang, H., Guo, B., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.038 · Cited by 53 · cited 2×
“4 articles [50,52,56,57] used morning light therapy [I(2) = 42%, SMD = -0.”
BackgroundMethodEfficacy of bright light therapy in bipolar depression
Yorguner Kupeli, N., Bulut, N. S., Carkaxhiu Bulut, G., Kurt, E., & Kora, K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.020 · Cited by 51
Sikkens, D., Riemersma - Van der Lek, R. F., Meesters, Y., Schoevers, R. A., & Haarman, B. C. M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.117 · Cited by 48 · cited 3×
“Because of the different research designs, the cohort studies [46–48,55] and RCTs [45,50,54] were analyzed separately.”
BackgroundResultPapatheodorou, G. N., & Kutcher, S. (1995) · PubMed · Cited by 48
Corticolimbic connectivity as a possible biomarker for bipolar disorder
Vai, B., Bollettini, I., & Benedetti, F. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.915744 · Cited by 44
Takeshima, M., Utsumi, T., Aoki, Y., Wang, Z., Suzuki, M., Okajima, I., Watanabe, N., Watanabe, K., & Takaesu, Y. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12976 · Cited by 43 · cited 2×
“some meta-analysis have suggested that BLT is effective [42–45], while others have shown that BLT does not have a significant antidepressant effect [46].”
BackgroundGrande, I., & Vieta, E. (2015) · CNS Drugs · doi:10.1007/s40263-015-0235-1 · Cited by 41
Bipolar disorder and bone health: A systematic review
Chandrasekaran, V., Brennan-Olsen, S. L., Stuart, A. L., Pasco, J. A., Berk, M., Hodge, J. M., & Williams, L. J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.013 · Cited by 39
What's New? The Clinical Epidemiology of Bipolar I Disorder
Sherazi, R., McKeon, P., McDonough, M., Daly, I., & Kennedy, N. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220601070047 · Cited by 36
Martiny, K., Lunde, M., Undén, M., Dam, H., & Bech, P. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00532.x · Cited by 35 · cited 1×
“Phototherapy is effective in treating depressive symptoms [39], and the sustained antidepressant effect of BLT has been confirmed in clinical studies [40,41].”
BackgroundMood and motor activity in euthymic bipolar disorder with sleep disturbance
Krane‐Gartiser, K., Steinan, M. K., Langsrud, K., Vestvik, V., Sand, T., Fasmer, O. B., Kallestad, H., & Morken, G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.012 · Cited by 33
International Consensus Group on Depression Prevention in Bipolar Disorder
Frye, M. A., Ha, K., Kanba, S., Kato, T., McElroy, S. L., Özerdem, A., Vázquez, G., & Vieta, E. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10123co1c · Cited by 31
The duration of light treatment and therapy outcome in seasonal affective disorder
Knapen, S. E., Werken, M. V. D., Gordijn, M. C. M., & Meesters, Y. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.034 · Cited by 30
Castellani, A., Girlanda, F., & Barbui, C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.032 · Cited by 25
What is the optimal implementation of bright light therapy for seasonal affective disorder (SAD)?
Levitan, R. D. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0512 · Cited by 23
Suzuki, M., Dallaspezia, S., Locatelli, C., Uchiyama, M., Colombo, C., & Benedetti, F. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.066 · Cited by 22
Light treatment in depression: An antique treatment with new insights
Geoffroy, P. A., Schroder, C. M., & Bourgin, P. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.03.002 · Cited by 22
Suzuki, M., Dallaspezia, S., Locatelli, C., Uchiyama, M., Colombo, C., & Benedetti, F. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.044 · Cited by 20 · cited 2×
“4 articles [50,52,56,57] used morning light therapy [I(2) = 42%, SMD = -0.”
BackgroundMethodEvans, M., Rohan, K. J., Sitnikov, L., Mahon, J. N., Nillni, Y. I., Tierney Lindsey, K., & Vacek, P. M. (2013) · Cognitive Therapy and Research · doi:10.1007/s10608-013-9561-0 · Cited by 17
Okasha, T. A., Fikry, M., Kowailed, A., El-Guwiely, T., & Sadek, H. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.007 · Cited by 15
Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression
Benedetti, F., Avery, D. H., Bauer, M., Bunney, W. E., Çaliyurt, O., Camardese, G., Colombo, C., Dallaspezia, S., Henriksen, T. E., Kasper, S., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020231 · Cited by 14
Wang, X., Zhao, N., Shi, J., Wu, Y., Liu, J., Xiao, Q. F., & Hu, J. (2019) · Journal of Medical Systems · doi:10.1007/s10916-019-1212-x · Cited by 10
Self-citationScandinavica, A. P., & Calabrese, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00534.x · Cited by 9
Martiny, K. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12219 · Cited by 3
Antidepressants and the Risk of Suicidal Behaviors—Reply
(2004) · JAMA · doi:10.1001/jama.292.23.2833-c · Cited by 3
(2018) · Current psychiatry · Cited by 3
Research works printed but not linked: 2
- Thompson C. Light therapy in the treatment of seasonal and non-seasonal affective disorders: A meta-analysis of randomised controlled trials. Journal of Affective Disorders. 2002; 68(1): 89–.
- Sit D, McGowan J, Wiltrout C, Weingarden J, Diler RS, Dills JL, et al A randomized, placebo-controlled trial of light therapy for bipolar depression: Antidepressant efficacy, side effects, changes in suicidality and sleep. Biological psychiatry. 2015; 77(9): 66S.
Cited by
Circadian disruption and human health
Fishbein, A. B., Knutson, K. L., & Zee, P. C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148286 · Cited by 468
Biological rhythms and chronotherapeutics in depression
Geoffroy, P. A., & Palagini, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110158 · Cited by 127
Madireddy, S., & Madireddy, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031844 · Cited by 89
Multi-Level Processes and Retina–Brain Pathways of Photic Regulation of Mood
Maruani, J., & Geoffroy, P. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020448 · Cited by 45
Bauer, M., Glenn, T., Achtyes, E. D., Alda, M., Ağaoğlu, E., Altınbaş, K., Andreassen, O. A., Angelopoulos, E. K., Ardau, R., Vares, E. A., et al. (2021) · International Journal of Bipolar Disorders · doi:10.1186/s40345-021-00231-7 · Cited by 35
Metadata
- Authors
- Wang, S., Zhang, Z., Yao, L., Ding, N., Jiang, L., & Wu, Y.
- Affiliations
- First Hospital of Lanzhou University (CN)
- Corresponding author
- Zhang, Zhigang
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-05-21
- Volume
- 15
- Issue
- 5
- Pages
- e0232798
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7241702
- OpenAlex
- W3027037284
- Cited by
- 35
- References
- 85
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 1
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lanzhou University Institutional Repository (submittedVersion, cc-by-nc-sa)
- Lanzhou University Institutional Repository (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Keywords
- bipolar disorder, bipolar depression, bright light therapy, color temperature, light intensity, depression severity, placebo comparison, treatment efficacy, subgroup analysis
- MeSH terms
- Bipolar Disorder, Depression, Female, Humans, Male, Phototherapy, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.